AOTI Inc.'s therapy received regulatory clearance from the FDA, with the company based in Galway and Oceanside.
2 reports, 2 independent
Updated Aug 16
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AOTI Inc.'s therapy received regulatory clearance from the FDA, with the company based in Galway and Oceanside.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.AOTI therapy progresses from FDA clearance to Medicare/CMS coverage evaluation.1 source
AOTI Inc. received regulatory clearance from the FDA for its therapy.1 source
Keep exploring
The entities involved
Related events
- FDA removed the clinical hold on Arbutus Biopharma Corporation's IND application, allowing potential clinical development.
- PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.
- Allarity Therapeutics has established a facility in Horsholm, Northern Europe, and the FDA requires CLIA certification for biomarker testing.
- Steriwave requires FDA approval for US market.
- FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.